IHC 2021 Archives - Medical Conferences

Home > Neurology > IHC 2021

International Headache Congress
8-12 September 2021

First real-world effectiveness data of erenumab-treated migraine in Switzerland

Trial

SQUARE

Conference

IHC 2021

14 September, 2021 11:27

Online First

Comparison of headaches after SARS-CoV-2 vaccination

Presented By

Dr Carl Göbel, Universitätsklinikum Schleswig-Holstein, Germany

Conference

IHC 2021

14 September, 2021 11:27

First real-world effectiveness data of erenumab-treated migraine in Switzerland

Trial

SQUARE

Conference

IHC 2021

14 September, 2021 11:27

Predictors of quality of life in cluster headache identified

Presented By

Dr Soo-Kyoung Kim, Gyeongsang National University, South Korea

Conference

IHC 2021

14 September, 2021 11:27

Combined GWAS analysis: robust evidence that cluster headache has genetic basis

Presented By

Dr Bendik Slagsvold Winsvold, Oslo University Hospital, Norway

Conference

IHC 2021

14 September, 2021 11:27

AI-enabled ECG algorithm predicts AF risk in migraine patients

Presented By

Dr Nikita Chhabra, Mayo Clinic, AZ, USA

Conference

IHC 2021

14 September, 2021 11:27

Patient experience of telemedicine for headache care during the pandemic

Conference

IHC 2021

13 September, 2021 11:33

Occipital nerve stimulation effective and safe in medically intractable chronic cluster headache

Presented By

Dr Poldi Wilbrink, Zuyderland Medical Centre, the Netherlands

Trial

Phase 3, ICON

Conference

IHC 2021

13 September, 2021 11:31

Insights in drug-drug interactions facilitate rational polypharmacy

Presented By

Dr Victor Kaytser, Rutgers Robert Wood Johnson Medical School, NJ, USA

Conference

IHC 2021

13 September, 2021 11:30

Largest genome-wide association study of migraine to date

Conference

IHC 2021

13 September, 2021 11:29

Anti-CGRP confers long term improvements in monthly migraine days

Trial

Phase 3, BHV3000-201

Conference

IHC 2021

13 September, 2021 11:28

Medical Conferences

IHC 2021

Featured articles

First real-world effectiveness data of erenumab-treated migraine in Switzerland

CONTENTS

Online First

Comparison of headaches after SARS-CoV-2 vaccination

First real-world effectiveness data of erenumab-treated migraine in Switzerland

Predictors of quality of life in cluster headache identified

Combined GWAS analysis: robust evidence that cluster headache has genetic basis

AI-enabled ECG algorithm predicts AF risk in migraine patients

Patient experience of telemedicine for headache care during the pandemic

Occipital nerve stimulation effective and safe in medically intractable chronic cluster headache

Insights in drug-drug interactions facilitate rational polypharmacy

Largest genome-wide association study of migraine to date

Anti-CGRP confers long term improvements in monthly migraine days